A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 --...

6

Transcript of A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 --...

Page 1: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 2: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 3: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 4: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 5: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and
Page 6: A New Ink On Pharma Life A Quarterly News Letter from Dept ... · diabetes. January 25, 2013 -- Oseni (alogliptin and pioglitazone) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and